Treatment Approach for Rhombencephalitis
Empiric treatment with intravenous aciclovir (10 mg/kg three times daily) and ampicillin should be started immediately in all cases of suspected rhombencephalitis, while awaiting diagnostic confirmation, as Listeria and HSV are the most common treatable causes. 1
Initial Management
- Patients with suspected rhombencephalitis require urgent neurological specialist assessment and should be managed in a setting where clinical neurological review can be obtained as soon as possible and definitely within 24 hours of referral 2
- Immediate neuroimaging with MRI (preferred) or CT should be performed, as nearly 100% of patients with rhombencephalitis have abnormal brain MRI findings 1, 3
- Lumbar puncture should be performed to obtain CSF for analysis, as 75% of patients with rhombencephalitis have CSF pleocytosis 1
- Blood cultures should be obtained before starting antimicrobial therapy, as they are crucial for diagnosing Listeria rhombencephalitis 1
Antimicrobial Therapy
For Suspected Viral Etiology:
- Intravenous aciclovir at 10 mg/kg three times daily should be started within 6 hours of admission if viral encephalitis is suspected 2
- For immunocompetent adults, continue aciclovir for 14-21 days for confirmed HSV encephalitis 2
- For VZV encephalitis, intravenous aciclovir 10-15 mg/kg three times daily is recommended, with dose adjustment for renal impairment 2
- For immunocompromised patients with HSV encephalitis, extend treatment to at least 21 days and perform repeat CSF PCR to confirm viral clearance 2
For Suspected Bacterial Etiology:
- Ampicillin is the treatment of choice for Listeria rhombencephalitis, the most common bacterial cause 1
- Antimicrobial therapy should be initiated as soon as possible after the diagnosis is considered likely, as bacterial meningitis/encephalitis is a neurological emergency 2
Adjunctive Therapy
- For VZV encephalitis with vasculitic component, consider adding a short course of corticosteroids (e.g., 60-80 mg of prednisolone daily for 3-5 days) 2
- For autoimmune or paraneoplastic causes of rhombencephalitis, immunosuppressive therapy with corticosteroids and either plasma exchange or IVIg may be beneficial 2
- Patients with falling level of consciousness require urgent ICU assessment for airway protection, ventilatory support, management of raised intracranial pressure, and optimization of cerebral perfusion 2
Specific Etiologies and Their Management
Listeria Rhombencephalitis:
- Most common infectious cause, primarily occurring in healthy young adults 1
- Presents with a biphasic course: flu-like syndrome followed by brainstem dysfunction 1
- Treatment is with ampicillin; duration should be based on clinical response 1
Viral Rhombencephalitis:
- HSV is the third most common infectious cause (after Listeria and Enterovirus 71) 1
- Mortality with aciclovir treatment is 22% versus 75% without aciclovir 1
- For VZV cerebellitis, antiviral treatments are not normally used as the disease is usually self-limiting 2
Autoimmune Rhombencephalitis:
- Behçet disease is the most common autoimmune etiology 1
- Treatment is with corticosteroids and immunosuppressive agents, but only 25% have complete recovery 1
- For NMDA receptor antibody-associated encephalitis, combination of corticosteroids with either plasma exchange or IVIg is recommended 2
Monitoring and Follow-up
- Repeat CSF PCR at the end of treatment course for HSV encephalitis to confirm clearance 2
- If CSF remains positive for HSV, continue aciclovir intravenously with weekly PCR until negative 2
- MRI is useful for follow-up examinations to assess treatment response 4
- Monitor renal function frequently when using aciclovir, as it can cause renal impairment through crystalluria in up to 20% of patients 2
Special Considerations
- In immunocompromised patients, consider a wider range of pathogens including CMV, EBV, toxoplasma, cryptococcus, and tuberculosis 2
- For immunocompromised children with VZV encephalitis, treatment duration may need to be longer than the standard 10 days 2
- Pediatric patients may present with atypical features such as bradycardia, requiring careful cardiac monitoring 5
Despite appropriate treatment, rhombencephalitis is associated with significant morbidity and mortality, making early diagnosis and prompt initiation of therapy crucial for improving outcomes 1, 6.